Literature DB >> 2984117

Partial deficiency of adrenal 11-hydroxylase. A possible cause of primary hypertension.

G de Simone, A P Tommaselli, R Rossi, R Valentino, R Lauria, F Scopacasa, G Lombardi.   

Abstract

Results of supraphysiological adrenocorticotropic hormone (ACTH) stimulation of biosynthetic pathways of adrenal zona fasciculata indicate that a deficiency of 11-hydroxylase exists in patients with essential hypertension. The deficiency is suggested by the much greater stimulus of synthesis of deoxycorticosterone (DOC) and deoxycortisol in hypertensive subjects than in controls (p less than 0.001). No significant difference in the synthesis of cortisol, corticosterone, progesterone, 17-hydroxyprogesterone (17-OHP), and delta-4-androstenedione (D4) was observed between the two groups. The ratios for synthesis of DOC and corticosterone and for deoxycortisol and cortisol found in hypertensive patients were significantly higher than those found in controls (p less than 0.001); no significant difference was observed in the synthesis of 17-OHP and progesterone. The synthesis of DOC and deoxycortisol was not significantly correlated with either blood pressure or plasma renin activity. Plasma renin activity was significantly lower in hypertensive subjects than in normotensive subjects (p less than 0.0001), while no difference was found in aldosterone secretion between the two groups. The 11-hydroxylase deficiency in the adrenal zona fasciculata may be one of the genetic factors causing hypertension together with environmental factors (particularly salt intake and work-related stress). The investigation performed in our study may be useful for the evaluation of adrenal zona fasciculata enzymatic activities during the study of hypertensive patients.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2984117     DOI: 10.1161/01.hyp.7.2.204

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  10 in total

Review 1.  Mechanisms of hypertension: the expanding role of aldosterone.

Authors:  E Marie Freel; John M C Connell
Journal:  J Am Soc Nephrol       Date:  2004-08       Impact factor: 10.121

2.  Low-renin primary hypertension in a young patient treated with dexamethasone.

Authors:  A P Tommaselli; G De Simone; L Di Lorenzo; R Rossi; A Cocca; R Valentino; B Biondi; G Lombardi
Journal:  J Endocrinol Invest       Date:  1986-02       Impact factor: 4.256

Review 3.  Low-renin hypertension of childhood.

Authors:  J DiMartino-Nardi; M I New
Journal:  Pediatr Nephrol       Date:  1987-01       Impact factor: 3.714

Review 4.  Hypertension and the expanding role of aldosterone.

Authors:  Scott M Mackenzie; John Connell
Journal:  Curr Hypertens Rep       Date:  2006-06       Impact factor: 5.369

5.  Functional hyperandrogenism detected by corticotropin and GnRH-analogue stimulation tests in women affected by apparently idiopathic hirsutism.

Authors:  R Rossi; L Tauchmanovà; A Luciano; R Valentino; S Savastano; C Battista; M Di Martino; G Lombardi
Journal:  J Endocrinol Invest       Date:  2001 Jul-Aug       Impact factor: 4.256

6.  Hexaconazole exposure ravages biosynthesis pathway of steroid hormones: revealed by molecular dynamics and interaction.

Authors:  Sayed Aliul Hasan Abdi; Abdulaziz Alzahrani; Saleh Alghamdi; Ali Alquraini; Adel Alghamdi
Journal:  Toxicol Res (Camb)       Date:  2021-12-16       Impact factor: 3.524

7.  Hyperinsulinaemia, dyslipidaemia and exaggerated adrenal androgen response to adrenocorticotropin in male smokers.

Authors:  A Hautanen; H Adlercreutz
Journal:  Diabetologia       Date:  1993-12       Impact factor: 10.122

8.  A pilot study for neonatal screening of congenital adrenal hyperplasia due to 21-hydroxylase and 11-beta-hydroxylase deficiency in Campania region.

Authors:  R Valentino; A P Tommaselli; R Rossi; G Lombardi; S Varrone
Journal:  J Endocrinol Invest       Date:  1990-03       Impact factor: 4.256

9.  Mild Adrenal Steroidogenic Defects and ACTH-Dependent Aldosterone Secretion in High Blood Pressure: Preliminary Evidence.

Authors:  João Martin Martins; Sónia do Vale; Ana Filipa Martins
Journal:  Int J Endocrinol       Date:  2014-12-15       Impact factor: 3.257

10.  A Novel Mutation in the CYP11B1 Gene Causes Steroid 11β-Hydroxylase Deficient Congenital Adrenal Hyperplasia with Reversible Cardiomyopathy.

Authors:  Mohammad A Alqahtani; Ayed A Shati; Minjing Zou; Ali M Alsuheel; Abdullah A Alhayani; Saleh M Al-Qahtani; Hessa M Gilban; Brain F Meyer; Yufei Shi
Journal:  Int J Endocrinol       Date:  2015-07-22       Impact factor: 3.257

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.